Related references
Note: Only part of the references are listed.Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
Babak Moghimi et al.
NATURE COMMUNICATIONS (2021)
Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma
Cristiana Angelucci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Low-grade gangliogliomas in adults: A population-based study
Xiaoning Lin et al.
CANCER MEDICINE (2021)
Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside
Julien Fleurence et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
Naxitamab, a new generation anti-GD2 monoclonal antibody (mAb) for treatment of relapsed/refractory high-risk neuroblastoma (HR-NB).
Jaume Mora et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
Glioneuronal tumors: clinicopathological findings and treatment options
Lidia Gatto et al.
FUTURE NEUROLOGY (2020)
New era of research on cancer-associated glycosphingolipids
Koichi Furukawa et al.
CANCER SCIENCE (2019)
Ceramide synthases in cancer therapy and chemoresistance
Sebastian Brachtendorf et al.
PROGRESS IN LIPID RESEARCH (2019)
Gangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived Tumors
Sumeyye Cavdarli et al.
BIOMOLECULES (2019)
Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients
Emanuele La Corte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
Tryggve Lundar et al.
ACTA NEUROCHIRURGICA (2018)
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
Taiji Iwasawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
EXTH-51. C18-CERAMIDE ANALOGUE DRUG OVERCOMES RESISTANCE TO TEMOZOLOMIDE IN GLIOBLASTOMA
Arabinda Das et al.
NEURO-ONCOLOGY (2018)
Epileptic seizures in anaplastic gangliogliomas
Marc Zanello et al.
BRITISH JOURNAL OF NEUROSURGERY (2017)
Overexpression of ceramide synthase 1 increases C18-ceramide and leads to lethal autophagy in human glioma
Zheng Wang et al.
ONCOTARGET (2017)
Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer
Sophie Groux-Degroote et al.
CHEMBIOCHEM (2017)
Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization
Dragana Fabris et al.
BIOCHIMIE (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma
Cady Ploessl et al.
ANNALS OF PHARMACOTHERAPY (2016)
Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity
Shih-Chi Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor and Yes Kinase
Yuki Ohkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis
Jean-Michel Lemee et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Ceramide synthases as potential targets for therapeutic intervention in human diseases
Joo-Won Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Database and data analysis application for structural characterization of gangliosides and sulfated glycosphingolipids by negative ion mass spectrometry
Marko Rozman et al.
CARBOHYDRATE RESEARCH (2014)
Bcl2L13 is a ceramide synthase inhibitor in glioblastoma
Samuel A. Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Chip-nanoelectrospray quadrupole time-of-flight tandem mass spectrometry of meningioma gangliosides: A preliminary study
Catalin Schiopu et al.
ELECTROPHORESIS (2012)
Chain length-specific properties of ceramides
Sabine Groesch et al.
PROGRESS IN LIPID RESEARCH (2012)
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Alfred H. Merrill
CHEMICAL REVIEWS (2011)
Malignant ganglioglioma: case report and review of literature
Ryan DeMarchi et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database
Senthil K. Selvanathan et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Assessment of the Molecular Expression and Structure of Gangliosides in Brain Metastasis of Lung Adenocarcinoma by an Advanced Approach Based on Fully Automated Chip-Nanoelectrospray Mass Spectrometry
Alina D. Zamfir et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2011)
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Manuel Nieto-Sampedro et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2011)
Significance of glycosphingolipid fatty acid chain length on membrane microdomain-mediated signal transduction
Kazuhisa Iwabuchi et al.
FEBS LETTERS (2010)
Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility
Sen-itiroh Hakomori
FEBS LETTERS (2010)
Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains
Adriane Regina Todeschini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components
Michel Mittelbronn et al.
NEUROPATHOLOGY (2007)
Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization
Zeljka Vukelic et al.
GLYCOBIOLOGY (2007)
Malignant and benign ganglioglioma: A pathological and molecular study
Ajay Pandita et al.
NEURO-ONCOLOGY (2007)
Primary spinal anaplastic ganglioglioma
H. Selim Karabekir et al.
PEDIATRIC NEUROSURGERY (2006)
Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid
S Hettmer et al.
BRITISH JOURNAL OF CANCER (2004)
The glioma-associated gangliosides 3′-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains
KM Hedberg et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
GM3 as a novel growth regulator for human gliomas
ENE Noll et al.
EXPERIMENTAL NEUROLOGY (2001)
Anencephaly:: Structural characterization of gangliosides in defined brain regions
Z Vukelic et al.
BIOLOGICAL CHEMISTRY (2001)
Ganglioside molecular species containing C18-and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures
S Sonnino et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES (2000)
Share Paper
